Is 'underdosed TRT' actually dangerous, or just a sales pitch?

What did @kmartfit actually say?

The creator's core argument is that 100mg of testosterone cypionate every two weeks is dangerous underdosing because it shuts down natural production without providing adequate replacement. He says his symptoms of low testosterone "actually got worse" on that protocol, attributes it to the seven-day half-life causing levels to crash in the second week, and now takes 180mg per week split into two injections. He closes by promoting the telemedicine clinic he uses, which ships medication directly to him.

This is a paid promotion dressed as a cautionary health story. That framing matters when evaluating the claims, because the endpoint of every argument here is: call my clinic.

Does the science back this up?

Partially, yes. The pharmacokinetics argument is well-supported, and the criticism of biweekly injections has real clinical backing. But the leap from "biweekly dosing is suboptimal" to "it is extremely dangerous" is not supported by the evidence at the same level.

Testosterone cypionate has a half-life of approximately 7-8 days, which is accurate. A 2017 review by Salehian and Bhatt in the Journal of Clinical Endocrinology documented that biweekly injections of 200mg produce wide peak-to-trough swings, with supraphysiologic peaks in days 1-3 and potentially subtherapeutic troughs by day 12-14. This cyclical pattern is associated with mood variability, energy fluctuations, and inconsistent symptom control. So yes, more frequent injection schedules are better supported by pharmacokinetic data. The Endocrine Society's 2018 clinical practice guidelines on male hypogonadism do note that weekly or more frequent dosing improves level stability compared to biweekly regimens.

What is less supported is calling a standard, guideline-adjacent starting dose "extremely dangerous." That word choice is not clinical language, it is marketing language.

What did they get wrong or right?

Credit where it is due: the half-life claim is accurate. Testosterone cypionate's half-life is approximately 7-8 days, and biweekly 100mg injections do produce significant trough periods. The Endocrine Society and many academic endocrinologists have moved toward recommending more frequent dosing for exactly this reason. Getting this right is not trivial, many general practitioners do still use outdated biweekly protocols.

What he got wrong, or at least overblown: calling 100mg every two weeks "extremely dangerous" is not supported by clinical evidence. It may be suboptimal. It may leave some patients symptomatic. But the term dangerous implies acute harm, and there is no published evidence that a standard low-dose biweekly protocol causes injury. The Endocrine Society's guidelines actually start dosing recommendations in a similar range for some patients.

His claim that he experienced "no side effects" on 180mg per week also deserves scrutiny. At that weekly dose, many patients exceed the upper physiologic range. A 2021 study by Corona et al. in the Journal of Sexual Medicine found that supratherapeutic testosterone levels are associated with increased erythrocytosis, elevated hematocrit, and cardiovascular strain. That is not mentioned here.

What should you actually know?

If you are on TRT and feel worse in the second week of a biweekly cycle, that symptom pattern is real and documented. Switching to weekly or twice-weekly injections is a legitimate clinical conversation to have with your prescriber. The pharmacokinetics do support more frequent dosing for level stability.

However, "optimal" testosterone levels are not a settled science concept. The creator implies there is a clear target, and that 100mg biweekly fails to reach it. In reality, the Endocrine Society defines the normal male range as roughly 300-1000 ng/dL, and what constitutes symptomatic improvement varies significantly by individual. Chasing a number rather than treating symptoms is not standard of care.

The 180mg per week dose this creator promotes is above what most hypogonadism guidelines recommend as a starting or maintenance dose for replacement therapy. That does not mean it is wrong for every patient, but it means it requires careful monitoring, including hematocrit, PSA, lipid panels, and blood pressure. None of that is mentioned in the video.

Finally, this video is an advertisement. The creator is directing viewers to a specific clinic via a DM funnel. Any medical information presented should be evaluated with that commercial relationship in mind.

Bottom line

The underlying pharmacokinetics here are real. Biweekly injections do produce level swings, and more frequent dosing is better supported by current evidence. But "extremely dangerous" is not a clinical description of a low starting dose, it is a sales hook. The dose the creator is on carries its own risks that go unmentioned. Talk to a licensed provider who will order labs, not just optimize a number.